X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
X4 Pharmaceuticals (Nasdaq: XFOR), a company focused on rare immune system diseases, has announced its participation in three major investor conferences in September 2024. These include:
- Morgan Stanley 22nd Annual Global Healthcare Conference on September 4
- Wells Fargo Healthcare Conference on September 5
- Cantor Fitzgerald Global Healthcare Conference on September 17
The company will engage in fireside chats and one-on-one meetings at these events. Live webcasts for the Morgan Stanley and Cantor Fitzgerald conferences will be available on X4's website, with replays accessible afterwards. Investors interested in one-on-one meetings should contact their respective conference representatives.
X4 Pharmaceuticals (Nasdaq: XFOR), una società focalizzata sulle malattie rare del sistema immunitario, ha annunciato la sua partecipazione a tre importanti conferenze per investitori a settembre 2024. Queste includono:
- 22° Conferenza annuale globale sulla salute di Morgan Stanley il 4 settembre
- Conferenza sulla salute di Wells Fargo il 5 settembre
- Conferenza globale sulla salute di Cantor Fitzgerald il 17 settembre
La società parteciperà a discussioni informali e incontri one-to-one durante questi eventi. Le dirette streaming per le conferenze di Morgan Stanley e Cantor Fitzgerald saranno disponibili sul sito web di X4, con riproduzioni disponibili successivamente. Gli investitori interessati a incontri one-to-one dovrebbero contattare i rispettivi rappresentanti delle conferenze.
X4 Pharmaceuticals (Nasdaq: XFOR), una empresa enfocada en enfermedades raras del sistema inmunológico, ha anunciado su participación en tres importantes conferencias de inversores en septiembre de 2024. Estas incluyen:
- 22ª Conferencia Anual Global de Salud de Morgan Stanley el 4 de septiembre
- Conferencia de Salud de Wells Fargo el 5 de septiembre
- Conferencia Global de Salud de Cantor Fitzgerald el 17 de septiembre
La empresa participará en charlas informales y reuniones individuales en estos eventos. Las transmisiones en vivo de las conferencias de Morgan Stanley y Cantor Fitzgerald estarán disponibles en el sitio web de X4, con repeticiones accesibles posteriormente. Los inversores interesados en reuniones individuales deben contactar a sus respectivos representantes de conferencia.
X4 제약 (Nasdaq: XFOR), 희귀 면역계 질환에 집중하는 회사는 2024년 9월에 열리는 세 가지 주요 투자자 회의에 참가한다고 발표했습니다. 이 회의는 다음과 같습니다:
- 모건 스탠리 제22회 연례 글로벌 헬스케어 회의 9월 4일
- 웰스 파고 헬스케어 회의 9월 5일
- 칸토르 피츠제럴드 글로벌 헬스케어 회의 9월 17일
회사는 이러한 행사에서 화로가 옆에서 진행되는 대화와 일대일 회의에 참여할 예정입니다. 모건 스탠리 및 칸토르 피츠제럴드 회의의 생중계는 X4의 웹사이트에서 제공되며, 이후 다시 볼 수 있습니다. 일대일 회의에 관심이 있는 투자자는 각 회의의 담당자에게 연락해야 합니다.
X4 Pharmaceuticals (Nasdaq: XFOR), une entreprise axée sur les maladies rares du système immunitaire, a annoncé sa participation à trois grandes conférences pour investisseurs en septembre 2024. Celles-ci incluent :
- 22e Conférence annuelle mondiale de la santé de Morgan Stanley le 4 septembre
- Conférence sur la santé de Wells Fargo le 5 septembre
- Conférence mondiale sur la santé de Cantor Fitzgerald le 17 septembre
L'entreprise participera à des discussions informelles et à des réunions individuelles lors de ces événements. Les diffusions en direct des conférences de Morgan Stanley et Cantor Fitzgerald seront disponibles sur le site Web de X4, avec des rediffusions accessibles par la suite. Les investisseurs intéressés par des réunions individuelles doivent contacter leurs représentants de conférence respectifs.
X4 Pharmaceuticals (Nasdaq: XFOR), ein Unternehmen, das sich auf seltene Erkrankungen des Immunsystems konzentriert, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im September 2024 bekannt gegeben. Dazu gehören:
- 22. Jährliche globale Gesundheitskonferenz von Morgan Stanley am 4. September
- Wells Fargo Gesundheitskonferenz am 5. September
- Cantor Fitzgerald globale Gesundheitskonferenz am 17. September
Das Unternehmen wird in diesen Veranstaltungen an informellen Gesprächen und persönlichen Treffen teilnehmen. Live-Übertragungen der Konferenzen von Morgan Stanley und Cantor Fitzgerald werden auf der Website von X4 verfügbar sein, mit Wiederholungen, die später abrufbar sind. Investoren, die an persönlichen Treffen interessiert sind, sollten ihre jeweiligen Konferenzvertreter kontaktieren.
- None.
- None.
BOSTON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in three upcoming investor conferences in September 2024:
Morgan Stanley 22nd Annual Global Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 2:35 PM EDT
Format: Fireside Chat and 1x1 Meetings
Webcast Link
Wells Fargo Healthcare Conference
Date: Thursday, September 5, 2024
Format: 1x1 Meetings
Cantor Fitzgerald Global Healthcare Conference
Date: Tuesday, September 17, 2024
Time: 3:40 PM EDT
Format: Fireside Chat and 1x1 Meetings
Webcast Link
The live webcasts for the Morgan Stanley 22nd Annual Global Healthcare Conference and the Cantor Fitzgerald Global Healthcare Conference will also be accessible through the investor relations section of X4 Pharmaceuticals’ website at www.x4pharma.com. Following the completion of these fireside chats, the webcast replays will be available on the X4 website.
For interested investors looking to schedule one-on-one meetings with company management, please contact your respective Morgan Stanley, Wells Fargo, or Cantor Fitzgerald representatives.
About X4 Pharmaceuticals
X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs. Leveraging our expertise in CXCR4 and immune system biology, we have successfully developed mavorixafor, which has received U.S. approval as XOLREMDI™ (mavorixafor) capsules in its first indication. We are also evaluating the use of mavorixafor in additional potential indications. X4 corporate headquarters are in Boston, Massachusetts and our research center of excellence is in Vienna, Austria. For more information, please visit our website at www.x4pharma.com.
Company Contact:
José Juves
Head of Corporate & Patient Affairs
jose.juves@x4pharma.com
Investor Contact:
Daniel Ferry
Managing Director, LifeSci Advisors
daniel@lifesciadvisors.com
(617) 430-7576
FAQ
What investor conferences will X4 Pharmaceuticals (XFOR) attend in September 2024?
Will there be webcasts available for X4 Pharmaceuticals' (XFOR) conference presentations?
How can investors schedule one-on-one meetings with X4 Pharmaceuticals (XFOR) management at these conferences?
What is the format of X4 Pharmaceuticals' (XFOR) participation in these September 2024 conferences?
